Walther Vogt

Walther Vogt's AcademicInfluence.com Rankings

Walther Vogt

Chemistry

#3946

World Rank

#4997

Historical Rank

chemistry Degrees

Walther Vogt

Biology

#10786

World Rank

#14142

Historical Rank

Molecular Biology

#1602

World Rank

#1630

Historical Rank

Biochemistry

#1734

World Rank

#1869

Historical Rank

biology Degrees

Download Badge

Chemistry
Biology

Walther Vogt's Degrees

PhD Biochemistry University of Zurich
Masters Chemistry University of Zurich

Why Is Walther Vogt Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Walther Vogt's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Oxidation of methionyl residues in proteins: tools, targets, and reversal. (1995) (819)
SIGNIFICANCE OF PHOSPHOLIPASE A FOR PROSTAGLANDIN FORMATION (1971) (267)
Anaphylatoxins: possible roles in disease. (1986) (123)
A new function of the activated third component of complement: binding to C5, an essential step for C5 activation. (1978) (122)
Role of phospholipase A2 in prostaglandin formation. (1978) (89)
Effects of local anaesthetics on prostaglandin biosynthesis in vitro. (1974) (85)
Kinin formation by plasmin, an indirect process mediated by activation of kallikrein (1964) (78)
Pharamacologically active acidic phospholipids and glycolipids. (1963) (77)
Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. I. Target cells and possible mode of action (1973) (73)
Alternative Pathway for the Activation of Complement in Human Serum. Formation and Composition of the Complex with Cobra Venom Factor that Cleaves the Third Component of Complement (2009) (71)
Complement activation by myeloperoxidase products released from stimulated human polymorphonuclear leukocytes. (1996) (64)
Activation, activities and pharmacologically active products of complement. (1974) (64)
Pharmacologically active substances formed in egg yolk by cobra venom (1957) (60)
Comparison of Naja n. naja and Naja h. haje cobra-venom factors: correlation between binding affinity for the fifth component of complement and mediation of its cleavage. (1980) (52)
Direct haemolytic activity of phospholipase A. (1972) (50)
Non-enzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5. (1989) (50)
Cleavage of the fifth component of complement and generation of a functionally active C5b6-like complex by human leukocyte elastase. (2000) (50)
Treatment of Human Complement Components C4 and C3 with Amines or Chaotropic Ions (1981) (48)
Indomethacin treatment of acute experimental pancreatitis in the rat. (1978) (45)
Mechanisms of complement activation by crystalline cholesterol. (1985) (40)
Aggregation of leukocytes induced by the complement-derived peptides C3a and C5a and by three synthetic formyl-methionyl peptides. (1980) (39)
Pharmacologically Active Lipid-Soluble Acids of Natural Occurrence (1957) (38)
Actions of anaphylatoxin on circulation and respiration of the guinea pig. (1967) (37)
Naturally occurring lipidsoluble acids of pharmacological interest. (1958) (36)
Complement activation by the properdin system: formation of a stoichiometric. C3 cleaving complex of properdin factor B with C36. (1977) (35)
Stimulation of B-cells by dextran sulphate in vitro. (1973) (34)
Plasma Kininogenases and Their Activators (1970) (34)
Activation of the fifth component of human complement, C5, without cleavage, by methionine oxidizing agents. (1992) (34)
Binding of phospholipase A to the direct lytic factor revealed by the interaction of Ca2+ with the haemolytic effect (1971) (32)
Demonstration of the Presence of Two Separate Kinin-Forming Systems in Human and Other Plasma (1966) (32)
Oxidants generated by the myeloperoxidase-halide system activate the fifth component of human complement, C5. (1994) (32)
Purification and some properties of a kininogenase from human plasma activated by surface contact. (1972) (28)
Stimulation of DNA synthesis in mouse lymphoid cells by polyanions in vitro. II. Relationship between adjuvant activity and stimulation of DNA synthesis by polyanions (1973) (28)
Preparation and some properties of anaphylatoxin from hog serum. (1968) (27)
Activation of the fifth component of human complement by oxygen-derived free radicals, and by methionine oxidizing agents: a comparison. (1992) (27)
Synergism between phospholipase A and various peptides and SH-reagents in causing haemolysis (1970) (26)
Complement activation in human lymph: modulation by the contact activation system and by leukocytes. (1986) (21)
Histamine release, formation of prostaglandin-like activity (SRS-C) and mast cell degranulation by the direct lytic factor (DLF) and phospholipase A of cobra venom (2004) (21)
Incompatibility between Complement Components C3 and C5 of Guinea‐Pig and Man, an Indication of their Interaction in C5 Activation by Classical and Alternative C5 Convertases (1979) (21)
Induction of platelet aggregation by the complement-derived peptides C3a and C5a (1976) (21)
Drugs and the complement system (1985) (19)
Chain Structure of Cobra Venom Factor from Naja naja and Naja haje venom (1982) (19)
Contraction of the guinea-pig ileum induced by anaphylatoxin independent of histamine release. (1970) (18)
Significance of direct and indirect kinin formation by plasmin in human plasma. (1971) (18)
Cleavage of the third complement component (C3) and generation of the spasmogenic peptide, C3a, in human serum via the properdin pathway: demonstration of inhibitory as well as enhancing effects of epsilon-amino-caproic acid. (1975) (18)
Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose. (1975) (18)
Effect of radiographic contrast media on complement components C3 and C4: generation of C3b-like C3 and C4b-like C4. (1983) (17)
Purification and partial amino acid sequence of classical anaphylatoxin from pig serum: identification with Des-Arg-C5a. (1980) (17)
Activation of the classical complement pathway by a polysaccharide from sugar cane. (1982) (17)
Biological activities of C5a and C5adesArg from hog serum. (1980) (17)
Functional identity of anaphylatoxin preparations obtained from different sources and by different activation procedures. 1. Pharmacological experiments. (1970) (16)
Amino-acid sequence and disulfide linkages of the anaphylatoxin, des-Arg omega-C5a, from porcine serum. (1984) (16)
Purification and some properties of a heat labile serum factor (UP); identity with glycine-rich beta-glycoprotein and properdin factor B. (1973) (16)
Effect of L-asparaginase and hydrocortisone on human lymphocyte transformation and production of a mononuclear leucocyte chemotactic factor in vitro. (1974) (16)
Stimulation of B cells by poly A: poly U and poly I: poly C in vitro. (1974) (15)
Mixed lymphocyte culture stimulatory and responding capacity of lymphocytes from patients with lymphoproliferative diseases. (1975) (14)
Activation of lymphocyte subpopulations in patients with chronic lymphocytic leukemia. (1978) (14)
Natural antibodies against a polysaccharide (Bo) from sugar cane mediate its complement-activating effect. (1983) (13)
The anaphylatoxin-forming system (1967) (13)
Inhibition of Na + - and K + -activated ATPase by the direct lytic factor of cobra venom (Naja naja). (1972) (13)
[Pharmacokinetics of 9 -fluorhydrocortisone]. (1971) (11)
Incompatibility between C3b and B of guinea-pig and man and its influence on the titration of the alternative pathway factors D and B in these two species. (1976) (11)
Role of the N-terminal regions of hog C3a, C5a and C5a-desArg in their biological activities. (1986) (11)
Formation of anaphylatoxin in rat plasma, a specific enzymic process. (1966) (11)
Multiple effects of a diamidine (propamidine) on complement activation. (1979) (10)
Purification and some properties of factor D of the human properdin system. (1976) (10)
Effect of metrizamide, a nonionic radiographic contrast agent, on human serum complement. Comparison with ionic contrast media. (1984) (10)
Prostaglandin: Liberation from and formation in perfused frog intestine (2005) (9)
Absorption of salicylic acid and its isomers from the rat jejunum (2004) (9)
Chemotactic effects of the complement-derived peptides C3a, C3ai and C5a (classical anaphylatoxin) on rabbit and guinea-pig polymorphonuclear leukocytes (1978) (9)
Adhesion of guinea pig polymorphonuclear leukocytes to autologous aortic strips: influence of chemotactic factors and of pharmacological agents which affect arachidonic acid metabolism. (1985) (9)
Factors in cobra venoms affecting the complement system. (1982) (8)
Role of histamine in the spasmogenic effect of the complement peptides C3a and C5a-desArg (classical anaphylatoxin) (1982) (7)
Effect of hog anaphylatoxin (C5a) on vascular permeability and leukocyte emigration in vivo (1976) (7)
Function of the activated fourth component of complement (C4b) in activation of C2 (1982) (7)
Effect of different penicillin derivatives on complement components in human serum. (1984) (7)
Separation, purification and properties of two proteins from rat serum which are essential for anaphylatoxin formation. (1967) (7)
Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan (1971) (7)
Studies on the relation between the fifth component of complement and anaphylatoxinogen (1971) (7)
Prostaglandin release from and formation in perfused frog intestine (2004) (6)
Pharmacological characterization of the slow component of deactivation of guinea-pig isolated ileum to the spasmogenic action of C5adesArg. (1985) (5)
'Inactivated' third component of complement (C3b-like C3; C3i) acquires C5 binding capacity and supports C5 activation upon covalent fixation to a solid surface. (1984) (5)
Loss and recovery of sensitivity of guinea-pig isolated ileum to the spasmogenic action of the complement peptide C5adesArg. (1985) (5)
Effect of different sulfonamides on the human serum complement system. (1985) (5)
[Formation of lipid soluble salts of acetycholine, Na, and Ca with phosphatidic acid as the receptor model]. (1963) (5)
Anaphylatoxin formation by contact activation of plasma. I. Activation by zymosan without participation of antibody (1971) (5)
Complex Formation of Properdin Factor B with C3b, an Essential Step in the Generation of the C3b Dependent C3 Cleaving Enzyme of the Properdin System (1976) (5)
Potentiation of haemolysis by the combined action of phospholipase A and a basic peptide containing S-S-bonds (Viscotoxin B) (1971) (5)
Lymphocyte transformation and production of a human mononuclear leucocyte chemotactic factor in patients with Hodgkin's disease. (1974) (5)
Interference of propamidine with binding of the fifth component of complement to surface-fixed C3b, and with C5 activation. (1979) (5)
[Pharmacologically active lipidsoluble acids in brain extracts: isolation of lysophosphatidic acid and ganglioside]. (1961) (5)
Functional identity of anaphylatoxin preparations obtained from different species and by different activation procedures. II. Immunological identity (1971) (4)
Factors and conditions essential for activation of the fifth component of complement and release of anaphylatoxin (C5a). (1977) (4)
Reduced glutathione and glutathione reductase-a comparative study of erythrocytes from various species. (1973) (4)
Possible implication of glutathione reductase in haemolysis by the direct lytic factor of cobra venom (Naja naja) (2004) (4)
Changes in Na+ and K+ permeability of red cells induced by the direct lytic factor of cobra venom and phospholipase A (2004) (4)
Influence of indometacin, phenylbutazone and BW 755C on different biological actions of C3a and C5a-desArg (1982) (4)
[ANAPHYLATOXIN FORMATION CAUSED BY PYROGENIC LIPOPOLYSACCHARIDE]. (1964) (4)
Intestinal absorption of a monoquaternary drug,14C-neostigmine (2005) (4)
Effects of the cleavage peptides, C3a and C3ai, from the third component of hog complement on leukocyte accumulation and vascular permeability in vivo (1978) (4)
[Antagonistic effect of atropine & morphine on the intestine-stimulating action of Darmstoff]. (1959) (4)
Purification of a human serum protein ("factor E") which enhances cobra venom factor-induced indirect lysis. Identification with the fifth component of complement. (1976) (4)
Effects of hydrocortisone treatment and whole body irradiation on mouse lymphocyte stimulation in vitro. (1973) (4)
Complement and Complement Reactions (1988) (4)
Generation of Anaphylatoxin Activity Related to C3a, by Treatment of Human Serum with the Nitrogen Nucleophile N2H4 or the Chaotrope KSCN (1985) (3)
Substrate modulation as a control mechanism in the activation of plasma multienzyme systems. (1979) (3)
[Intestine-stimulating activity of various phosphatides and glycolipids]. (1960) (3)
Immunization against cobra venom (2005) (3)
Binding characteristics of the complement peptides C3a and C5a-desArg to cellulose nitrate filters in Boyden chambers. (1983) (3)
[Chemical & pharmacological properties of acid phospholipids (Darmstoff)]. (1958) (3)
Fast deactivation of guinea-pig isolated ileum to C5adesArg: a possible cyclic AMP-dependent mechanism. (1985) (3)
LIBERATION OF PHARMACOLOGICALLY ACTIVE LIPIDS BY ENZYMES CONTAINED IN TOXINS (1965) (3)
[Absorption of phenol red from the rat small intestine]. (1967) (3)
Hydrolytic Activation of the Fifth Component of Complement (C5) by C3 Convertases Depends on its Binding to Surface-fixed C3b; Specific Interference with Binding, by Properdin, Factor B, or Propamidine, Leads to Inhibition of C5 Cleavage and Utilization (1978) (3)
Activation of the complement system (1983) (3)
[Hydrogen peroxide as the carrier of the intestinal stimulating effect of polyunsturated fatty acids]. (1962) (2)
[The material basis of bowel movements and of the intestinal vagus stimulation]. (1949) (2)
Neo-antigen(s) on human C3b, indicating a specific structure possibly related to its function(S) (1982) (2)
An Active Kallikrein-α 2 -Macroglobulin Complex Generated by Treatment of Human Plasma with Acetone (1976) (2)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 94 (1982) (2)
Formation of mixed aggregates of human polymorphonuclear leukocytes and platelets by C5a-desArg. (1991) (2)
Formation of anaphylatoxin in human serum (2005) (2)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 102 (1985) (1)
Differences in binding of the direct lytic factor (DLF) of cobra venom (Naja naja) to intact red cells and ghosts (1973) (1)
Identification of a Heat Labile Human Serum Factor (UF) with GBG; Participation in Anaphylatoxin-Forming Systems (1973) (1)
Osmotic and non-osmotic components of the haemolysis induced by the direct lytic factor (DLF) of cobra venom (2004) (1)
Binding of phospholipase A to the cirect lytic factor revealed by the interaction of Ca 2+ with the haemolytic effect. (1971) (1)
Inefficient Utilization of the Fifth Component of Guinea Pig Complement in Cobra Venom Factor-Induced Complement Lysis; Efficient Utilization of Human C5 (1976) (1)
Generation of an esterolytic and kinin-forming kallikrein-α2-macroglobulin complex in human serum by treatment with acetone (1976) (1)
Substrate Modulation as a Control Mechanism of Plasma Multienzyme Systems (1979) (1)
Darmstoff, a gut-stimulating compound occurring in the intestinal wall. (1954) (1)
[On the 70th birthday of professor Dr. L. Lendle]. (1969) (1)
[Formation by phospholipase A of SRS-C in perfused guinea pig lung. Identification with prostaglandin]. (1969) (1)
Symposium on physiologically active lipid acids: 14 September. Leiden, Holland (1963) (1)
[THE IMPORTANCE OF GLUCURONIDE FORMATION AND SPLITTING FOR THE FATE OF DIHYDROXYDIPHENYL-PYRIDYLMETHANE]. (1965) (1)
[Effect of anaphylatoxin (AT) upon capillary permeability in guinea pig skin]. (1970) (1)
An Alternative Scheme of Kinin Formation during Contact Activation of Human Plasma (1972) (1)
Anaphylatoxin formation by contact activation of plasma III. Fixation of two different anaphylatoxin‐forming complexes on zymosan (1972) (1)
[Properties and preparation of Darmstoff]. (1955) (0)
[Further studies on the existence of 2 kinin-forming systems in human plasma]. (1968) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 101 (1984) (0)
[DEACETYLATION AND ABSORPTION OF PHENOLATED LAXATIVES]. (1965) (0)
[Nature of the kinins formed in human plasma by pancreatic kallikrein, glass contact and acid treatment]. (1967) (0)
[Analgesic effect of D-phenylalanine]. (1986) (0)
1166 – ACTIVATION OF THE PROPERDIN SYSTEM IN HUMAN SERUM, IN VITRO, BY ANTIFIBRINO- LYTIC AGENTS (1977) (0)
Proceedings: Effect of the complement-derived peptides C3a and C5a (anaphylatoxin) on platelets of different species, in vitro. (1975) (0)
Contents, Vol. 78, 1985 (1985) (0)
[Serum kininogenases and their activation]. (1968) (0)
Activation of human lymphocyte subpopulations by protein a from staphylococcus aureus bacteria (1979) (0)
Studies on Binding of the Direct Lytic Factor (DLF) of Cobra Venom (Naja naja) to Red Cell Membranes (1974) (0)
ACTIVATION OF ISOLATED T CELLS IN CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) BY MITOGENS (1977) (0)
Function of the activated fourth component of complement (C4b) in activation of C2 (1982) FEBS Letters 144, 195‐198. (1982) (0)
[Effect of biogenetic substances on intestinal motility]. (1953) (0)
Proceedings: Cleavage of the third complement component (C3) and release of a spasmogenic, C3-derived peptide (C3a) by epsilon-aminocaproic acid (EACA) in serum: a process involving the complement activating properdin system. (1974) (0)
[Sympathomimetics aralcylized by the Kulz method; their effects on the smooth musculature of isolated organs]. (1952) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 79 (1977) (0)
[Lymphocyte stimulation in patients in the chronic lymphatic leukemia: separation of peripheral lymphocytes through a discontinuous albumin density gradient]. (1973) (0)
[Kininogen specificity of aceton-activated human plasma kallikrein]. (1969) (0)
New trends in the pharmacology of peptides and proteins. Introduction. (1971) (0)
Correlation between aggregative and Chemotaxis inducing activities of five chemotactic peptides (Abstract) (1980) (0)
[Studies on the existence of 2 different kinin-forming systems in human plasma]. (1967) (0)
Contents, Vol. 79, 1986 (1986) (0)
[Identification of the Substance DS as 5-hydroxytryptamine]. (1954) (0)
[Influence of blood enzymes and bivalent cations on anaphylatoxin formation]. (1963) (0)
The role of plasmin for kinin formation in human plasma (2006) (0)
[Substrate specificity of glass-activated kininogenase from bovine plasma]. (1969) (0)
[Spontaneous formation of prostaglandin in the isolated frog intestine]. (1968) (0)
An active kallikrein-α(in2)-macroglobulin complex generated by treatment of human plasma with acetone (1976) (0)
[Histamine-independent effects of anaphylatoxin on smooth muscle of isolated organs]. (1969) (0)
[Prostaglandine in a darmstoff preparation from frog intestine]. (1965) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 90 (1981) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 92 (1982) (0)
Lymphocyte function in patients with Hodgkin's disease. (1975) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 99 (1984) (0)
[Existence of two different substances exciting intestines in intestinal extracts, not identical with histamine and choline]. (1952) (0)
[Resorption of a hydrophilic acid (phenol red) from the rat small intestine]. (1967) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 98 (1983) (0)
[Separation of an anaphylatoxin-forming principle from other venom components in cobra venom]. (1964) (0)
[Effect of pH on the intestinal absorption of a hydrophilic base, 14C-neostigmine]. (1970) (0)
[Contraction of the guinea pig intestine and histamine liberation: 2 separate independent effects of anaphylotoxin]. (1970) (0)
[Laxatives, effects and dangers]. (1971) (0)
News Item / Erratum (1985) (0)
[Studies on the nature of the H substance]. (1956) (0)
2208 – INHIBITION OF PROSTAGLANDIN TRANSPORT BY LOCAL ANAESTHETICS (1978) (0)
The Formation, Actions and Properties of Anaphylatoxin (1968) (0)
2263 – COMPLEMENT INHIBITION BY PROPAMIDINE, A BASIS OF ITS CHEMOTHERAPEUTIC EFFECT? (1978) (0)
[Clinical comparison of the effects of largactil and serpasil]. (1956) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 96 (1981) (0)
Interference by a new inhibitor of cobra venom (CI) with binding of the second component of complement to C4b (1982) (0)
[Relationship between Vogt's intestinal extract substance and von Euler and Gaddum's P substance]. (1950) (0)
[Dependence of the contraction effect of phosphatidic acid and acetylcholine on taenia coli upon the extracellular ion content]. (1965) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 73 (1975) (0)
[Relation of intestinal substance to the substance P. 3..]. (1953) (0)
Pharmaceutical Manipulations of the Complement Cascade (1988) (0)
[Chromatography of intestine-stimulating, lipidsoluble acids of Si02]. (1960) (0)
Formation of a kininogenase-α2macroglobulin complex during activation of human plasma with acetone (1975) (0)
Absence of non-DFP-Inhibitable Activities of Factor D̄ (1978) (0)
Influence of a bagasse glucan (B0) on leukocyte aggregation and accumulation. (1985) (0)
[Relationship between Vogt's intestinal extract substance and von Euler and Gaddum's P substance]. (1950) (0)
[Liberation of histamine and serotonin from rabbit platelets induced by agar]. (1968) (0)
Contents, Vol. 39, 1970 (1970) (0)
Effects on leukocyte accumulation in vivo of the spasmogenically active (C3a) and inactive (C3ai) cleavage peptides of the third component of complement. (1977) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 93 (1983) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 89 (1981) (0)
[The second German Convallaria standard]. (1967) (0)
[Not Available]. (1949) (0)
Inhibition of Complement Activation by the Chemotactic Drug, Propamidine (1978) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 95 (1983) (0)
Contents, Vol. 73, 1984 (2004) (0)
Contents, Vol. 63, 1980 (1980) (0)
[Kininogen specificity of acetone-activated human plasma]. (1968) (0)
[On the nature of the "slow-reacting substance" liberated by cobra venom in the perfused guinea pig lung]. (1961) (0)
Differentiation between formation, in plasma, of anaphylatoxin and of endogenous pyrogen (2005) (0)
[ABSORPTION OF DRUGS BY DIFFUSION]. (1965) (0)
Reviews of Physiology, Biochemistry and Pharmacology, Volume 97 (1984) (0)
Limiting factors of the anaphylatoxin forming system in plasma from different species (2005) (0)

This paper list is powered by the following services:

Walther Vogt's Academic­Influence.com Rankings

Walther Vogt's Degrees

Why Is Walther Vogt Influential?

Walther Vogt's Published Works

Published Works

Walther Vogt's AcademicInfluence.com Rankings